Insights - BIO

Areas of Work

	BIO Fully Supports President's Ban On Genetic Discrimination Feb 8 2000 WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on President Clinton's executive order...
	BIO Responds To President Clinton's State Of The Union Speech Jan 27 2000 WASHINGTON, D.C. (Jan. 27, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement on Medicare reform proposals made by President Clinton...
	President Clinton Proclaims January 2000 National Biotechnology Month Jan 21 2000 WASHINGTON, D.C. (Jan. 21, 1999) Not too long ago, the idea of treating the root causes of diseases was just that, an idea. And so was the prospect of feeding hungry nations on dwindling farm land...
	Biotech Starts 2000 With A Bang As Recent Gains Rival Internet Stocks Jan 20 2000 CEO & Investor Conference To Showcase Industry To New Investors WASHINGTON, D.C. (January 20, 2000) Recent gains inbiotechnology stocks have rivaled the performance of Internet...
	BIO’s First TV Ad on the Air Jan 18 2000 WASHINGTON, D.C. (January 14, 2000) A BIO-sponsored television ad will begin running Jan. 17 on cable and news talk shows throughout the Washington metropolitan area. The ad focuses on the...
	Biotech Drug Approvals Top 90 With Hundreds More In Late-Stage Clinical Trials Jan 18 2000 WASHINGTON, D.C. (Jan. 18, 2000) Another 22biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration (FDA) in 1999. That...
	Countdown to BIO 2000 Press Can Register Now! Jan 11 2000 Washington, D.C. (January 11, 2000) The Biotechnology Industry Organization (BIO) will host its 14th International Biotechnology Meeting and Exhibition two months earlier than usual this year. BIO...
	Judah Folkman, Jurgen Drews Keynote Speakers Conference Dec 20 1999 WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global research and development for F. Hoffmann-La...
	BIO Puts Forth Gene Therapy Oversight Proposal Dec 7 1999 WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient events in gene therapy clinical...
	The Passing of Bob Swanson Dec 6 1999 (Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6, 1999) -- ôAs a co-founder of...